Moderna's mRNA HIV vaccine trial kicks off with first round of doses

Moderna has just announced the launch of the first clinical trial for an HIV vaccine made using its messenger RNA (mRNA) technology, and the first doses have already been administered to enrolled participants. The use of mRNA tech is a major milestone in the multi-decade effort to develop an HIV vaccine, arriving decades after the first vaccine clinical trial was …